Cite
HARVARD Citation
Injac, S. et al. (n.d.). MBRS-56. SYSTEMATIC DRUG REPURPOSING IDENTIFIES DIGOXIN AS A DRUG THAT PROLONGS SURVIVAL IN PDOX MODELS OF GROUPS 3 AND 4 MEDULLOBLASTOMA AT CLINICALLY RELEVANT DOSES. Neuro-oncology. 20 (2), p. i140. [Online].